165
Views
10
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Asthma Medication Is Increasingly Prescribed for Finnish Olympic Athletes—For a Reason?

, M.D., , M.D., Ph.D., , Ph.D., , M.D. & , M.D.
Pages 744-749 | Published online: 09 Aug 2012

References

  • Helenius IJ, Tikkanen HO, Sarna S, Haahtela T. Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol 1998; 101:646–652.
  • Lumme A, Haahtela T, Ounap J, Rytila P, Obase Y, Helenius M, Remes V, Helenius I. Airway inflammation, bronchial hyperresponsiveness and asthma in elite ice hockey players. Eur Respir J 2003; 22:113–117.
  • Maiolo C, Fuso L, Todaro A, Anatra F, Boniello V, Basso S, De Lorenzo A, Pistelli R. Prevalence of asthma and atopy in Italian olympic athletes. Int J Sports Med 2004; 25:139–144.
  • Thomas S, Wolfarth B, Wittmer C, Nowak D, Radon K, GA2LEN-Olympic study-Team. Self-reported asthma and allergies in top athletes compared to the general population: results of the German part of the GA2LEN-Olympic study 2008. Allergy Asthma Clin Immunol 2010; 6:31.
  • Moreira A, Delgado L, Carlsen KH. Exercise-induced asthma: why is it so frequent in Olympic athletes? Expert Rev Respir Med 2011; 5: 1– 3.
  • Fitch KD, Sue-Chu M, Anderson SD, Boulet LP, Hancox RJ, McKenzie DC, Backer V, Rundell KW, Alonso JM, Kippelen P, Cummiskey JM, Garnier A, Ljungqvist A. Asthma and the elite athlete: summary of the International Olympic Committee’s consensus conference, Lausanne, Switzerland, January 22–24, 2008. J Allergy Clin Immunol 2008; 122:254–60, 260.e1–7.
  • Wolfarth B, Wuestenfeld JC, Kindermann W. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes. Endocrinol Metab Clin North Am 2010; 39:75–87, ix.
  • Pluim BM, de Hon O, Staal JB, Limpens J, Kuipers H, Overbeek SE, Zwinderman AH, Scholten RJ. Beta (2)-agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials. Sports Med 2011; 41:39–57.
  • World Anti-Doping Agency. The World Anti-Doping Code. Available at: http://www.wada-ama.org. Accessed January 4, 2012.
  • Ansley L, Kippelen P, Dickinson J, Hull JH. Misdiagnosis of exercise-induced bronchoconstriction in professional soccer players. Allergy 2012; 67:390–395.
  • Haahtela T, Malmberg P, Moreira A. Mechanisms of asthma in Olympic athletes: practical implications. Allergy 2008; 63:685–694.
  • Weiler JM, Ryan III EJ. Asthma in United States Olympic athletes who participated in the 1998 Olympic Winter Games. J Allergy Clin Immunol 2000; 106:267–271.
  • Alaranta A, Alaranta H, Palmu P, Alha P, Pietila K, Heliovaara M, Helenius I. Asthma medication in Finnish Olympic athletes: no signs of inhaled beta2-agonist overuse. Med Sci Sports Exerc 2004; 36: 919– 924.
  • Dohi M, Komatsu Y, Yamasawa F, Akama T, Watanabe K, Hasegawa A, Hirashima M, Fujita Y, Ota K, Kawahara T. Determination of the prevalence of bronchial asthma (BA) and development of an effective protocol to detect BA in Japanese elite athletes. Br J Sports Med 2011; 45:318.
  • Locke S, Marks G. Are the prevalence and treatment of asthma similar in elite athletes and the aged-matched non-athlete population? Scand J Med Sci Sports 2007; 17:623–627.
  • Lund T, Pedersen L, Larsson B, Backer V. Prevalence of asthma-like symptoms, asthma and its treatment in elite athletes. Scand J Med Sci Sports 2009; 19:174–178.
  • Tanaka J, Hasegawa T, Koya T, Hashiba M, Omori G, Gejyo F, Suzuki E, Arakawa M. Pulmonary function analysis of Japanese athletes: possibly even more asthmatics in the field. Allergol Int 2010; 59:53–57.
  • Corrigan B, Kazlauskas R. Medication use in athletes selected for doping control at the Sydney Olympics (2000). Clin J Sport Med 2003; 13:33–40.
  • Tsitsimpikou C, Tsiokanos A, Tsarouhas K, Schamasch P, Fitch KD, Valasiadis D, Jamurtas A. Medication use by athletes at the Athens 2004 Summer Olympic Games. Clin J Sport Med 2009; 19:33–38.
  • Simons FE, Gerstner TV, Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 1997; 99:655–659.
  • Haney S, Hancox RJ. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 2006; 31:181–196.
  • Martinez FD. Serious adverse events and death associated with treatment using long-acting beta-agonists. Clin Rev Allergy Immunol 2006; 31:269–278.
  • Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 2002; 16:1068–1070.
  • Haney S, Hancox RJ. Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials. Respir Res 2007; 8:19.
  • Hancox RJ, Aldridge RE, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Town GI, Taylor DR. Tolerance to beta-agonists during acute bronchoconstriction. Eur Respir J 1999; 14:283–287.
  • Helenius I, Rytila P, Sarna S, Lumme A, Helenius M, Remes V, Haahtela T. Effect of continuing or finishing high-level sports on airway inflammation, bronchial hyperresponsiveness, and asthma: a 5-year prospective follow-up study of 42 highly trained swimmers. J Allergy Clin Immunol 2002; 109:962–968.
  • Chowdhury BA, Seymour SM, Levenson MS. Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma. N Engl J Med 2011; 364:2473–2475.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.